Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Prostatic Neoplasms 8Glioblastoma 7Urinary Bladder Neoplasms 6Breast Neoplasms 6Oropharyngeal Neoplasms 5Neoplasm Metastasis 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Carcinoma 5Burkitt Lymphoma 5Astrocytoma 5Sarcoma 4Squamous Cell Carcinoma of Head and Neck 3Rhabdomyosarcoma, Embryonal 3Pancreatic Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Glioma 3Esophageal Neoplasms 3Adenocarcinoma of Lung 3Triple Negative Breast Neoplasms 2Sarcoma, Synovial 2Sarcoma, Ewing 2Rhabdomyosarcoma, Alveolar 2Rhabdomyosarcoma 2Rectal Neoplasms 2Prostate Adenocarcinoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Melanoma 2

Interventions

Temozolomide 4Cyclophosphamide 4X-Rays 3Vincristine 3Specimen Handling 3Phantoms, Imaging 3Magnetic Resonance Spectroscopy 3Ifosfamide 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2selpercatinib 2ivosidenib 2cabozantinib 2Topotecan 2Radiation 2Nuclear Medicine Department, Hospital 2Irinotecan 2Congresses as Topic 2trifluridine tipiracil drug combination 1tazemetostat 1talazoparib 1palbociclib 1olaparib 1liposomal doxorubicin 1larotrectinib 1irinotecan sucrosofate 1ganitumab 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Radiation × 30 days × Clear all
NCT02306161 2026-05-27

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
312 enrolled 14 charts
Sarcoma

Sarcoma, Ewing

NCT07188532 2026-05-11

BEAR

Mayo Clinic

Phase NA Recruiting
141 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡